Learn more

ASHMONT HOLDINGS LTD

Overview
  • Total Patents
    79
About

ASHMONT HOLDINGS LTD has a total of 79 patent applications. Its first patent ever was published in 1994. It filed its patents most often in Australia, New Zealand and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets pharmaceuticals, basic materials chemistry and medical technology are G POHL BOSKAMP GMBH & CO KG, ENCORE VISION INC and ANTONY BENNY.

Patent filings per year

Chart showing ASHMONT HOLDINGS LTDs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Harvey Colin Manson 48
#2 Razzak Majid Hameed Abdul 15
#3 Holmes Robert William Lachlan 10
#4 Colin Manson Harvey 6
#5 Mcarthur Morgan John 5
#6 Loveridge Ivor Blair 5
#7 Nilendu Sen 5
#8 Jindal Kour Chand 4
#9 Fenton Murray Edward 3
#10 Rao Bantupalli 2

Latest patents

Publication Filing date Title
AU2006100530A5 Levamisole, Avermectins or similsr in pyrrolidone solvent
AU2004101083A4 Anthelmintic compositions
AU2004101082A4 Anthelmintic compositions
AU2004101084A4 Anthelmintic compositions
BRPI0404600A low irritation pour-on compositions
NZ530286A Anthelmintic formulations containing triclabendazole
NZ530386A Container
NZ535644A Anthelmintic formulations
NZ523128A Anthelmintic formulations containing avermectins and or milbemycins
NZ520295A Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
NZ517227A Sheep pour-on formulation comprising avermectins or milbemycins, a penetrating agent and a solvent
AU9743801A Anthelmintic formulations
NZ514279A Intraruminal device for dispensing medication where device has arms that open to keep the device in the animal's rumen after a constraint device dissolves
NZ530317A Intraruminal device
NZ513665A Intraruminal device
NZ513664A Long acting formulations
EP1320385A1 Combination compositions
NZ512948A Veterinary compositions containing both hydrophilic and lipophilic actives
AU7463000A Sheep pour-on
NZ548401A Stable liquid antihelmintic solution comprising triclabandazole dissolved in at least one solvent